...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells
【24h】

KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells

机译:KLF8参与TGF-beta诱导的EMT,并促进胃癌细胞的侵袭和迁移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: Krüppel-like factor 8 (KLF8), a downstream transcription factor of transforming growth factor-β1 (TGF-β1), has a role in tumorigenesis, tumor progress and epithelial-to-mesenchymal transition (EMT) induction. Recent studies mainly focused on its role in breast cancer and hepatocellular carcinoma; however, little is studied in gastric cancer. Here, we aim to explore whether KLF8 is involved in TGF-β1-induced EMT in gastric cancer cells. Methods: Western blot and real-time PCR assays were used to detect the expression of KLF8, E-cadherin and vimentin in gastric cancer cell line SGC7901 treated with or without TGF-β1. The lentivirus-mediated RNA interference technique was used to knock down the expression of KLF8 in gastric cancer cell line SGC7901. In vitro, the ability of cell migration and invasion were measured by transwell and wound healing assays; the cell motility was detected by high content screening assay. Results: TGF-β1 could induce EMT via down-regulating E-cadherin and up-regulating vimentin expression in gastric cancer cells. Further study found that TGF-β1 could induce KLF8 expression at the protein and mRNA levels in gastric cancer cells (P < 0.05). Western blot and real-time PCR assays found that small interference RNA (siRNA)-mediated KLF8 silence blocked TGF-β1-induced EMT-like transformation and subsequently reversed the loss of E-cadherin and gain of vimentin. In vitro, inhibition of KLF8 decreased TGF-β1-prompted cell migration, invasion and motility. Conclusions: KLF8, a transcription factor, is involved in TGF-β1-induced EMT in gastric cancer cells and may be a novel therapeutic target for the treatment of gastric cancer.
机译:目的:Krüppel样因子8(KLF8)是转化生长因子β1(TGF-β1)的下游转录因子,在肿瘤发生,肿瘤进展和上皮-间质转化(EMT)诱导中起作用。最近的研究主要集中在其在乳腺癌和肝细胞癌中的作用。然而,关于胃癌的研究很少。在这里,我们旨在探讨KLF8是否参与TGF-β1诱导的胃癌细胞EMT。方法:采用Western blot和实时荧光定量PCR检测TGF-β1对胃癌细胞SGC7901细胞中KLF8,E-cadherin和波形蛋白的表达。慢病毒介导的RNA干扰技术被用于敲除胃癌细胞SGC7901中KLF8的表达。在体外,通过transwell和伤口愈合测定法测量细胞迁移和侵袭的能力。通过高含量筛选试验检测细胞运动性。结果:TGF-β1可通过下调E-钙黏着蛋白和上调波形蛋白的表达来诱导EMT。进一步的研究发现,TGF-β1可以诱导胃癌细胞KLF8在蛋白质和mRNA水平上的表达(P <0.05)。 Western印迹和实时PCR分析发现,小干扰RNA(siRNA)介导的KLF8沉默阻止了TGF-β1诱导的EMT样转化,并随后逆转了E-钙粘蛋白的丢失和波形蛋白的获得。在体外,抑制KLF8可降低TGF-β1促进的细胞迁移,侵袭和运动能力。结论:转录因子KLF8与TGF-β1诱导的胃癌细胞EMT有关,可能是胃癌治疗的新靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号